The latest report titled "Immunohistochemistry Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics [Cancer, Infectious, Autoimmune Diseases], Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028" projects significant growth in the global immunohistochemistry market. According to the report, the market is anticipated to reach USD 4.7 billion by 2028, up from USD 3.2 billion in 2023, reflecting a notable CAGR of 7.4% during the forecast period of 2023 to 2028.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939
The driving forces behind this growth include several key factors. Firstly, the increase in the geriatric population and the consequent rise in cancer cases globally have significantly contributed to market expansion. Secondly, technological advancements in Immunohistochemistry (IHC) have enhanced its diagnostic capabilities, making it an increasingly preferred method across various medical applications. Furthermore, the availability of reimbursements for IHC tests has facilitated broader adoption.
However, despite the positive outlook, certain factors may impede market growth. The presence of alternative tests and the significant market consolidation by major players are expected to pose challenges during the forecast period.
The report highlights the remarkable growth in the Kits product segment within the immunohistochemistry market. In 2022, this segment witnessed the highest growth rate, attributed to the growing demand for comprehensive solutions from single, reliable providers. Ready-to-use kits streamline the IHC process, eliminating the time-consuming selection of primary antibodies and stains, thus fostering market growth.
In terms of applications, while diagnostic and research segments dominate the market, the forensic application segment accounted for the smallest share in 2022. Although IHC plays a crucial role in forensic pathology, particularly in determining the cause of death, its applications are limited due to tissue degradation post-mortem.
Among end users, hospitals and diagnostic laboratories represent the largest segment, driven by the increasing number of specialty diagnostic tests and the rising trend of in-house diagnostic capabilities. The Asia-Pacific region emerges as the fastest-growing market, propelled by economic growth, rising chronic diseases prevalence, increasing healthcare spending, and government initiatives promoting healthcare awareness and accessibility.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939
Key players in the global immunohistochemistry market include F. Hoffman-La Roche AG, Danaher Corporation, and Agilent Technologies, Inc.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]